practolol has been researched along with aspirin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Castleden, CM; Raymond, K; Volans, CN | 1 |
| Johnson, M; Kot, PA; Ramwell, PW; Rose, JC | 1 |
| Crowley, HJ; Dalton, C; Shtacher, G | 1 |
| Schröder, R | 1 |
| Slezak, H | 1 |
1 review(s) available for practolol and aspirin
| Article | Year |
|---|---|
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
9 other study(ies) available for practolol and aspirin
| Article | Year |
|---|---|
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
The effect of ageing on drug absorption from the gut.
Topics: Administration, Oral; Adult; Aged; Aging; Aspirin; Biological Availability; Humans; Intestinal Absorption; Intestine, Small; Practolol | 1977 |
Cardiovascular and platelet responses in the dog to the monoenoic prostaglandin precursor dihomo-gamma-linolenic acid.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Aspirin; Blood Platelets; Blood Pressure; Depression, Chemical; Dogs; Fatty Acids, Unsaturated; Female; Hexamethonium Compounds; Linoleic Acids; Male; Myocardial Contraction; Palmitic Acids; Platelet Adhesiveness; Platelet Aggregation; Practolol; Prostaglandins E; Prostaglandins F; Stimulation, Chemical | 1975 |
Inhibition of platelet aggregation by papaverine-like drugs: evidence for a novel mechanism of action.
Topics: Adenosine Diphosphate; Aspirin; Collagen; Epinephrine; Humans; Indomethacin; Isoproterenol; Papaverine; Phentolamine; Platelet Aggregation; Practolol; Propranolol; Tretoquinol | 1976 |
[Drug-induced eye lesions in the aged].
Topics: Aged; Antipsychotic Agents; Aspirin; Cataract; Conjunctival Diseases; Corneal Diseases; Eye Diseases; Fluorouracil; Glaucoma; Humans; Lacrimal Apparatus; Optic Nerve Diseases; Phenothiazines; Practolol; Retinal Diseases | 1983 |